Tag: NaviGate

NaviGate Cardiac Structures Inc. (“NCSI”) reports “excellent valvular function” at 1-year follow-up of first patient to receive GATE™ tricuspid valved stent via transjugular access

Coronary/Structural Heart by 0 comments

LAKE FOREST, Calif.–(BUSINESS WIRE)–NaviGate Cardiac Structures Inc. (“NCSI”) announced today that the first patient to receive its replacement tricuspid valved stent via transjugular access has reached one-year post-procedure with excellent valvular function. This patient, along with 15 others treated to date […]

Continue Reading →

NaviGate Cardiac Structures, Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient

Coronary/Structural Heart by 0 comments

LAKE FOREST, Calif., Aug. 30, 2017 – NaviGate Cardiac Structures Inc. (“NCSI”) announced today that its GATE™ catheter-guided tricuspid atrioventricular valved stent (A VS) was implanted through the jugular vein six weeks ago into a patient’s transplanted heart that was […]

Continue Reading →